-
unsuccessful in 2005, the
company soon
underwent a
reverse takeover with
Micromet.
CancerVax was
founded in
Delaware by Dr.
Donald Morton in 1998. Prior...
- MT103) was
developed by a German-American
company Micromet, Inc. in
cooperation with Lonza; In 2012,
Micromet was
purchased by Amgen,
which furthered the drug's...
-
cytotoxic activity,
against cancer cells. BiTE is a
registered trademark of
Micromet AG (fully
owned subsidiary of
Amgen Inc).
BiTEs are
fusion proteins consisting...
-
seniors in
rural areas and
reduce overall Medicare spending.
Amgen acquired Micromet, a
company focused on BiTE technology, in March. In May,
Kevin Sharer retired...
- head of drug
discovery at
Tularik Inc., as
chief scientific officer at
Micromet Inc., and as a vice
president research for
Amgen Inc. in Munich, Germany...
- in
plaque psoriasis and
rheumatoid arthritis.
Namilumab was
produced by
Micromet Inc and is
under development by
Takeda Pharmaceuticals International. World...
-
Merck & Co. (Merck
Sharp & Dohme) MLN –
Millennium Pharmaceuticals MT –
Micromet,
acquired by
Amgen in 2012 NBI –
Neurocrine Biosciences NC –
Nycomed NC...
-
Journal of Immunotherapy. 32 (5): 452–64. doi:10.1097/CJI.0b013e3181a1c097. PMID 19609237. S2CID 25568468. "BiTE
Antibody Platform".
Micromet Inc. v t e...
- Corixa), HenaQuest, IDEC
Pharmaceuticals (merged with Biogen), LigoCyte,
Micromet (formerly CancerVax),
Morphotek (Acquired by
Eisai Corporation), Sequana...
- Pharmaceuticals, Crucell,
deCODE genetics, Delinia, Exelixis, IFM
Therapeutics Inc.,
Micromet,
Momenta Pharmaceuticals, MorphoSys,
Nimbus Apollo, Novexel,
Padlock Therapeutics...